Active Surveillance
Oncology·MeSH: Carcinoma, Renal Cell
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| CAN-2409 | Candel Therapeutics, Inc. (CADL) |
Unknown(1)
| Drug | Company |
|---|---|
| Prolaris | MYRIAD GENETICS INC (MYGN) |
Compare drugs
Frequently asked questions
How many drugs are in development for Active Surveillance?
BioSniper tracks 2 drugs in development for Active Surveillance across 2 companies.
How many clinical trials target Active Surveillance?
There are 1 clinical trial targeting Active Surveillance tracked by BioSniper.
Deep-dive into Active Surveillance
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis